🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.

Several professionals stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the platform has taken down violative material and prohibited associated keywords and query recommendations. The organization stated it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

After moments of entering one group, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.

Item Information and Costs

Inside these communities, posts display dark colored packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to potentially serious medical dangers”.